Literature DB >> 1696191

The antiperinuclear factor. I. Clinical and serologic associations.

P Youinou1, P Le Goff, A Dumay, A Lelong, P Fauquert, J Jouquan.   

Abstract

The antiperinuclear factor (APF) test raises two main problems: the unpredictability of the cells used as substrate and the difficulty in expressing the results. We propose that 10% of the cells have to be stained by a given serum in order for it to be considered positive. APF were found to be present in 76% of rheumatoid arthritis (RA) patients, 3% of healthy controls and occasionally in disease controls. The production of APF was significantly (p less than 0.01) related to the presence of rheumatoid factor in RA, and IgG antibody was predominant in the APF test.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1696191

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


  11 in total

Review 1.  Rheumatology.

Authors:  R A Asherson; R Cervera; D P D'Cruz; G R Hughes
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

2.  The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies.

Authors:  M Sebbag; M Simon; C Vincent; C Masson-Bessière; E Girbal; J J Durieux; G Serre
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

3.  Antiperinuclear factor in the polyarticular form of juvenile chronic arthritis: are use of frozen material or age of patients relevant?

Authors:  J M Berthelot
Journal:  Ann Rheum Dis       Date:  1995-01       Impact factor: 19.103

Review 4.  HLA-B27 associated spondyloarthropathy, an autoimmune disease based on crossreactivity between bacteria and HLA-B27?

Authors:  J H Ringrose
Journal:  Ann Rheum Dis       Date:  1999-10       Impact factor: 19.103

5.  Anti-perinuclear factor compared with the so called "antikeratin" antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides.

Authors:  C Vincent; F de Keyser; C Masson-Bessière; M Sebbag; E M Veys; G Serre
Journal:  Ann Rheum Dis       Date:  1999-01       Impact factor: 19.103

6.  Diagnostic and prognostic values of anti glucose-6-phosphate isomerase antibodies in community-recruited patients with very early arthritis.

Authors:  F Jouen; O Vittecoq; F Leguillou; I Tabti-Titon; J F Menard; O Mejjad; S Pouplin; P Boumier; P Fardellone; A Gayet; D Gilbert; F Tron; X Le Loët
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

7.  Occurrence of antiperinuclear, antikeratin, and anti-RA 33 antibodies in juvenile chronic arthritis.

Authors:  C Gabay; A M Prieur; O Meyer
Journal:  Ann Rheum Dis       Date:  1993-11       Impact factor: 19.103

8.  Comparison of three anti-CCP antibody tests and rheumatoid factor in RA and control patients.

Authors:  Ma Lurdes Correia; Saudade Carvalho; Jorge Fortuna; Ma Henriqueta Pereira
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

9.  Autoantibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non-citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid arthritis.

Authors:  O Vittecoq; B Incaurgarat; F Jouen-Beades; J Legoedec; O Letourneur; D Rolland; G Gervasi; J F Ménard; A Gayet; P Fardellone; A Daragon; M Jolivet; X le Loët; F Tron
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

10.  Antiperinuclear factor: a useful test for the diagnosis of rheumatoid arthritis.

Authors:  S Muñoz-Fernández; R Alvarez-Doforno; M Cuesta; A Balsa; G Fontán; J Gijón-Baños
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.